FIRST REPORTS OF THE NEW SPATZ 3 ADJUSTABLE BALLOON SYSTEM
Presentation at Canadian DDW Conference, February 2014
Jeffrey Brooks1, Zbigniew Kowalcyk2, Sameer Al Awadhi3, M. Al Falasi3, John Mason4, Laszlo Bene5, Evgen Machytka6, Samer El Asala7, Valenti Puig-Divi8
1. Spatz FGIA, NY, United States. 2. Bariatric Clinic of Lodz, Lodz, Poland.3. Rashid Hospital, Dubai, United Arab Emirates. 4. National Obesity Surgery Center, Manchester, United Kingdom.5. Rozsakert Medical Center, Budapest, Hungary.6. University Hospital of Ostrava, Ostrava, Czech Republic.7. Alain Hospital, Dubai, United Arab Emirates. 8. Opcion Medical Clinic, Barcelona, Spain.
Background: The original Spatz Adjustable Balloon System for weight loss was introduced in 2010. It was the first intragastric balloon approved for 1 year implantation with the added feature of balloon volume adjustability. This enabled changes to balloon volume during the course of the 1 year implantation period. It contained a rigid catheter and metal chain that caused duodenal migration. The new Spatz 3 intragastric balloon device, CE Mark approval in 2012, has a soft catheter to simplify the procedure and decrease complications. In addition, reports of volume adjustments using a mean 177 ml yields additional 1.7 kg/month wt loss. It has been suggested that adjusting with larger volumes will yield better results. We report our experience with the Spatz 3 device in 7 centers.
Aims: To determine the difference between the reported results of the original Spatz Adjustable balloon System and the new Spatz3 Adjustable balloon System with respect to ease of use, complications, weight loss results and the effect of larger volume adjustments.